SCIE.09.2
AAV-mediated inhibition of miR-181a/b as gene-independent therapeutic tool for mitochondrial diseases
14/03/2023 09:20
SCIE.13.2
Nuclease-free targeted integration of a promoter-less mini-ATP7B confers proliferative advantage to edited hepatocytes and corrects Wilson disease
14/03/2023 14:20
SCIE.13.4
EXPEDITing AAV gene therapy
14/03/2023 15:00